よくわかるIgG4関連疾患

出版社： 中外医学社
著者：
発行日： 2017-04-15
分野： 臨床医学：内科  >  膠原病/リウマチ
ISBN： 9784498026100
電子書籍版： 2017-04-15 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,720 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,720 円(税込)

購入する

商品紹介

瞬く間に世界中に広まった「IgG4関連疾患」．その疾患領域はどんどん広がり，あらゆる臓器でIgG4関連疾患の炎症が証明されている．一方，鑑別の紛らわしい多数の類縁症例が診断を困難にしている．本書では，本疾患のエキスパートである，内科臨床医・病理診断医・放射線科医が共同し，豊富な症例を元に，その鑑別に力点を置いて実践的な解説を加えた．

目次

  • よくわかるIgG4関連疾患

    ―目次―

    I　総論
    　1．内科臨床の立場から
    　2．病理診断科の立場から
    　3．放射線科の立場から

    II　症例編
    　1．IgG4関連疾患
    　2．類縁疾患

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 総論

P.21 掲載の参考文献
1) Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539-51.
PubMed
2) Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease.Lancet. 2015;385:1460-71.
PubMed
3) Kawa S, Kawano M. IgG4-related disease:an overview. In:Umehara H, et al, editors. IgG4-related disease. Tokyo:Springer;2013. p. 3-7.
 
4) Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-8.
PubMed
5) Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403-4.
 
6) Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease.J Gastroenterol. 2003;38:982-4.
PubMed
7) Takeda S, Haratake J, Kasai T, et al. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant. 2004;19:474-6.
 
8) Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis. 2004;43:e18-25.
 
9) Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm:close relationship to IgG4-related periaortitis. Am J Surg Pathol. 2008;32:197-204.
PubMed
10) Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease(IgG4RD):general concept and details. Mod Rheumatol. 2012;22:1-14.
PubMed
11) Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061-7.
PubMed
12) Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease:dataset of 235 consecutive patients. Medicine(Baltimore). 2015;94:e680.
PubMed
13) Uchida K, Tanaka T, Gershwin ME, et al. The Geoepidemiology and Clinical Aspects of IgG4-Related Disease. Semin Liver Dis. 2016;36:187-99.
PubMed
14) Masaki Y, Kurose N, Yamamoto M, et al. Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease. Int J Rheumatol. 2012;2012:580814.
PubMed
15) Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease:a prospective study of 118 Chinese patients. Rheumatology(Oxford). 2015;54:1982-90.
 
16) Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease:Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67:2466-75.
PubMed
17) Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome:analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310-5.
PubMed
18) Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615-26.
PubMed
19) 佐藤康晴, 吉野正. リンパ節病変. In:川茂幸, 他編. IgG4関連疾患アトラス. 金沢:前田書店;2012. p165-72.
 
20) Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006;32:16-21.
PubMed
21) Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016-23.
PubMed
22) Saeki T, Kawano M, Mizushima I, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int. 2013;84:826-33.
PubMed
23) Mizushima I, Yamada K, Fujii H, et al. A case of IgG4-related kidney disease first detected because of severe renal dysfunction. In:Umehara H, et al, editors. IgG4-related disease. Tokyo:Springer;2013. p. 213-8.
 
24) Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343-52.
PubMed
25) Yamaguchi Y, Kanetsuna Y, Honda K, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012;43:536-49.
PubMed
26) Kawano M, Saeki T. IgG4-related kidney disease--an update. Curr Opin Nephrol Hypertens. 2015;24:193-201.
PubMed
27) Kawano M, Suzuki Y, Yamada K, et al. Primary Sjogren's syndrome with chronic tubulointerstitial nephritis and lymphadenopathy mimicking IgG4-related disease. Mod Rheumatol. 2015;25:637-41.
PubMed
28) Nakashima Y, Nakamura H, Horai Y, et al. Comorbid case of IgG4-related disease and primary Sjogren's syndrome. Mod Rheumatol. 2015;25:462-7.
PubMed
29) Ayuzawa N, Ubara Y, Keiichi S, et al. Churg-Strauss syndrome with a clinical condition similar to IgG4-related kidney disease:a case report. Intern Med. 2012;51:1233-8.
PubMed
30) Iguchi A, Wada Y, Kobayashi D, et al. A case of MPO- and PR3-ANCA-positive hypertrophic cranial pachymeningitis with elevated serum IgG4. Mod Rheumatol. 2013;23:151-5.
PubMed
31) Yamamoto M, Takahashi H, Suzuki C, et al. Analysis of serum IgG subclasses in Churg-Strauss syndrome--the meaning of elevated serum levels of IgG4. Intern Med. 2010;49:1365-70.
PubMed
32) Vaglio A, Strehl JD, Manger B, et al. IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis. 2012;71:390-3.
PubMed
33) Chang SY, Keogh KA, Lewis JE, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis(Wegener's):a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44:2432-7.
 
34) Lighaam LC, Rispens T. The Immunobiology of Immunoglobulin G4. Semin Liver Dis. 2016;36:200-15.
PubMed
35) Ozden I, Dizdaroglu F, Poyanli A, et al. Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitis. Pancreatology. 2005;5:300-3.
PubMed
36) Miura H, Miyachi Y. IgG4-related retroperitoneal fibrosis and sclerosing cholangitis independent of autoimmune pancreatitis. A recurrent case after a 5-year history of spontaneous remission. JOP. 2009;10:432-7.
PubMed
37) Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061-7.
PubMed
38) Sugumar A, Kloppel G, Chari ST. Autoimmune pancreatitis:pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol. 2009;104:2308-10.
PubMed
39) Kawa S, Hamano H, et al. Autoimmune pancreatitis and IgG4-related disease. In:Rose N, et al, editors. The Autoimmune Diseases. 5th ed. St Louis:Academic Press;2013. p. 935-49.
 
40) Kawa S, Okazaki K, Kamisawa T, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol. 2014;49:765-84.
PubMed
41) Shimosegawa T, Chari ST, Frulloni L, et al. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis:Guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352-8.
PubMed
42) Toki F, Kozu T, et al. An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP-A report of four cases. Endoscopy. 1992;24:640.
 
43) Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis:CT and MR characteristics. AJR Am J Roentgenol. 1998;170:1323-7.
 
44) Maruyama M, Watanabe T, Kanai K, et al. Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis. 2014;9:77.
PubMed
45) Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536-42.
 
46) Tanaka A, Tazuma S, Okazaki K, et al. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci. 2014;21:43-50.
PubMed
47) Nakazawa T, Ohara H, Sano H, et al. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.
 
48) Naitoh I, Nakazawa T, Ohara H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol. 2009;44:1147-55.
 
49) Goto H, Takahira M, Azumi A, et al. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1-7.
 
50) Yamamoto M, Ohara M, Suzuki C, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz's disease. Scand J Rheumatol. 2004. 33:432-3.
PubMed
51) Japanese study group of IgG4-related ophthalmic disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;57:573-9.
 
52) Yamamoto M, Nojima M, Takahashi H, et al. Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment. Rheumatology. 2015. 54:45-9.
PubMed
53) Takahashi H, Yamamoto M, Tabeya T, et al. The immunobiology and clinical characteristics of IgG4 related diseases. J Autoimmun. 2012;39:93-6.
PubMed
54) Sogabe Y, Ohshima K, Azumi A, et al. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol. 2014;252:531-8.
PubMed
55) Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. J Am Soc Nephrol. 2013;83:455-62.
 
56) Horita S, Fujii H, Mizushima I, et al. A case of IgG4-related tubulointerstitial nephritis and membranous glomerulonephritis during the clinical course of gastric cancer:Imaging features of IgG4-related kidney disease. Mod Rheumatol. 2016 Oct 27:1-5. [Epub ahead of print]
 
57) Kawano M, Yamada K. IgG4-Related Kidney Disease and IgG4-Related Retroperitoneal Fibrosis. Semin Liver Dis. 2016;36:283-90.
PubMed
58) Kasashima S, Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol. 2011;23:18-23.
PubMed
59) Mizushima I, Inoue D, Yamamoto M, et al. Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis:a retro-spective multicenter study. Arthritis Res Ther. 2014;16:R156.
 
60) Mizushima I, Inoue D, Kawano M. Retroperitoneal fibrosis/periaortitis and hydronephrosis. In:Saito T, et al, editors. IgG4-related kidney disease. Tokyo:Springer;2016. p. 159-71.
 
61) Tajima M, Hiroi Y, Takazawa Y, et al. Immunoglobulin G4-related multiple systemic aneurysms and splenic aneurysm rupture during steroid therapy. Hum Pathol. 2014;45:175-9.
PubMed
62) Kasashima S, Kawashima A, Kasashima F, et al. Immunoglobulin G4-related periaortitis complicated by aortic rupture and aortoduodenal fistula after endovascular AAA repair. J Endovasc Ther. 2014;21:589-97.
PubMed
63) Kasashima S, Kawashima A, Endo M, et al. A clinicopathologic study of immunoglobulin G4-related disease of the femoral and popliteal arteries in the spectrum of immunoglobulin G4-related periarteritis. J Vasc Surg. 2013;57:816-22.
PubMed
64) Matsumoto Y, Kasashima S, Kawashima A, et al. A case of multiple immunoglobulin G4-related periarteritis:a tumorous lesion of the coronary artery and abdominal aortic aneurysm. Hum Pathol. 2008;39:975-80.
PubMed
65) Stone JH, Khosroshahi A, Deshpande V, et al. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res(Hoboken). 2010;62:316-22.
PubMed
66) Kasashima S, Zen Y, Kawashima A, et al. A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta. J Vasc Surg. 2010;52:1587-95.
PubMed
67) Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis:CT findings in 17 patients. Radiology. 2011;261:625-33.
PubMed
68) Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease:CT findings with pathologic correlations. Radiology. 2009;251:260-70.
PubMed
69) Fujinaga Y, Kadoya M, Kawa S, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol. 2010;76:228-38.
PubMed
70) Matsui S, Hebisawa A, Sakai F, et al. Immunoglobulin G4-related lung disease:clinicoradiological and pathological features. Respirology. 2013;18:480-7.
PubMed
71) Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease:a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33:1886-93.
PubMed
72) Mori K, Yamada K, Konno T, et al. Pericardial Involvement in IgG4-related Disease. Intern Med. 2015;54:1231-5.
PubMed
73) Hourai R, Miyamura M, Tasaki R, et al. A case of IgG4-related lymphadenopathy, pericarditis, coronary artery periarteritis and luminal stenosis. Heart Vessels. 2016;31:1709-13.
PubMed
74) Khosroshahi A, Wallace ZS, Crowe JL, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67:1688-99.
PubMed
75) Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011. Mod Rheumatol. 2012;22:21-30.
PubMed
76) 日本膵臓学会・厚生労働省難治性膵疾患に関する調査研究班. 自己免疫性膵炎臨床診断基準2011. 膵臓. 2012;27:17-25.
Medical*Online
77) 厚生労働省IgG4関連全身硬化性疾患の診断法の確立と治療方法の開発に関する研究班, 厚生労働省難治性の肝胆道疾患に関する調査研究班, 日本胆道学会. IgG4関連硬化性胆管炎臨床診断基準2012. 胆道. 2012;26:59-63.
Medical*Online
78) 正木康史, 梅原久範. IgG4関連疾患～その診断の混沌, および混沌から抜け出すための提言～. 日臨免誌. 2009;32:478-83.
 
79) Goto H, Takahira M, Azumi A;Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1-7.
 
80) 松井祥子, 山本洋, 源誠二郎, 他. 第54回日本呼吸器学会学術講演会 シンポジウム報告IgG4関連呼吸器疾患の診断基準. 日呼吸誌. 2015;4:129-32.
 
81) Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181-92.
PubMed
82) Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961-70.
PubMed
83) Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis:a multicentre, international analysis. Gut. 2013;62:1771-6.
PubMed
84) Masamune A, Nishimori I, Kikuta K, et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2016 Aug 19. pii:gutjnl-2016-312049. doi:10.1136/gutjnl-2016-312049. [Epub ahead of print]
 
85) Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease:a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171-7.
PubMed
86) Wallace ZS, Mattoo H, Mahajan VS, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology(Oxford). 2016;55:1000-8.
PubMed
87) Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22:414-8.
PubMed
88) Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610-7.
 
89) Asano J, Watanabe T, Oguchi T, et al. Association Between Immunoglobulin G4-related Disease and Malignancy within 12 Years after Diagnosis:An Analysis after Longterm Followup. J Rheumatol. 2015;42:2135-42.
PubMed
90) Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis:a case-control study and review of the literature. Pancreas. 2014;43:417-21.
PubMed
91) Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53:171-6.
PubMed
92) Wallace ZS, Wallace CJ, Lu N, et al. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016;68:2283-9.
PubMed
93) Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-8.
 
94) Morgan WS, Castleman B. A clinicopathologic study of Mikulicz's disease. Am J Pathol. 1953;29:471-503.
PubMed
95) Watanabe T, Maruyama M, Ito T, et al. Two siblings with type 1 autoimmune pancreatitis. Intern Med. 2013;52:895-9.
PubMed
P.36 掲載の参考文献
1) Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539-51.
PubMed
2) Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181-92.
PubMed
3) Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis:do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193-203.
PubMed
4) Zen Y, Nakanuma Y. IgG4-related disease:a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812-9.
PubMed
5) Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease:a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33:1886-93.
PubMed
6) Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64:237-43.
PubMed
P.45 掲載の参考文献
1) Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539-51.
PubMed
2) Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181-92.
PubMed
3) Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease:dataset of 235 consecutive patients. Medicine(Baltimore). 2015;94:e680.
PubMed
4) Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-8.
PubMed
5) Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403-4.
 
6) Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis:CT and MR characteristics. AJR Am J Roentgenol. 1998;170:1323-7.
 
7) Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis:imaging features. Radiology. 2004;233:345-52.
PubMed
8) Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis:guidelines of the international association of pancreatology. Pancreas. 2011;40:352-8.
PubMed
9) Inoue D, Gabata T, Matsui O, et al. Autoimmune pancreatitis with multifocal mass lesions. Radiat Med. 2006;24:587-91.
PubMed
10) Ichikawa T, Sou H, Araki T, et al. Duct-penetrating sign at MRCP:usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221:107-16.
PubMed
11) Sugiyama Y, Fujinaga Y, Kadoya M, et al. Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer. Jpn J Radiol. 2012;30:296-309.
 
12) Wakabayashi T, Kawaura Y, Satomura Y, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation:comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98:2679-87.
 
13) Takahashi N, Kawashima A, Fletcher JG, et al. Renal involvement in patients with autoimmune pancreatitis:CT and MR imaging findings. Radiology. 2007;242:791-801.
 
14) Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615-26.
PubMed
15) Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm:close relationship to IgG4-related periaortitis. Am J Surg Pathol. 2008;32:197-204.
PubMed
16) Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis:CT findings in 17 patients. Radiology. 2011;261:625-33.
PubMed
17) Mizushima I, Inoue D, Yamamoto M, et al. Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis:a retrospective multicenter study. Arthritis Res Ther. 2014;16:R156.
PubMed
18) Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease:a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33:1886-93.
PubMed
19) Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease:CT findings with pathologic correlations. Radiology. 2009;251:260-70.
PubMed
20) Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor(plasma cell granuloma)of the lung. Hum Pathol. 2005;36:710-7.
PubMed
21) Taniguchi T, Ko M, Seko S, et al. Interstitial pneumonia associated with autoimmune pancreatitis. Gut. 2004;53:770-1.
PubMed
22) Sato Y, Kojima M, Takata K, et al. Systemic IgG4-related lymphadenopathy:a clinical and pathologic comparison to multicentric Castleman's disease. J Clin Pathol. 2010;63:1084-9.
 
23) Inoue D, Zen Y, Sato Y, et al. IgG4-Related Perineural Disease. Int J Rheumatol. 2012;2012:401890.
PubMed
24) Graham RP, Smyrk TC, Chari ST, et al. Isolated IgG4-related sclerosing cholangitis:a report of 9 cases. Hum Pathol. 2014;45:1722-9.
PubMed
25) Zen Y, Fujii T, Sato Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol. 2007;20:884-94.
PubMed

II 症例編

P.59 掲載の参考文献
1) Nakanuma Y, Zen Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis:The latest addition to the sclerosing cholangitis family. Hepatol Res. 2007;37 Suppl 3:S478-86.
 
2) Zen Y, Fujii T, Sato Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol. 2007;20:884-94.
PubMed
3) Umemura T, Zen Y, Hamano H, et al. IgG4 associated autoimmune hepatitis:a differential diagnosis for classical autoimmune hepatitis. Gut. 2007;56:1471-2.
PubMed
4) Umemura T, Zen Y, Hamano H, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol. 2011;46 Suppl 1:48-55.
 
5) Umemura T, Zen Y, Hamano H, et al. Immunoglobin G4-hepatopathy:association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology. 2007;46:463-71.
PubMed
6) Nakanuma Y, Ishizu Y, Zen Y, et al. Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease. Semin Liver Dis. 2016;36:229-41.
PubMed
7) Takahashi N, Kawashima A, Fletcher JG, et al. Renal involvement in patients with autoimmune pancreatitis:CT and MR imaging findings. Radiology. 2007;242:791-801.
 
8) Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615-26.
PubMed
9) Kim F, Yamada K, Inoue D, et al. IgG4-related tubulointerstitial nephritis and hepatic inflammatory pseudotumor without hypocomplementemia. Intern Med. 2011;50:1239-44.
PubMed
10) Inoue D, Zen Y, Sato Y, et al. IgG4-Related Perineural Disease. Int J Rheumatol. 2012;2012:401890.
PubMed
11) Saeki T, Kawano M, Mizushima I, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int. 2013;84:826-33.
PubMed
12) Mizushima I, Yamamoto M, Inoue D, et al. Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease:a retrospective multicenter study. Arthritis Res Ther. 2016;18:273.
PubMed
P.72 掲載の参考文献
1) Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181-92.
PubMed
2) Watanabe T, Fujinaga Y, Kawakami S, et al. Infraorbital nerve swelling associated with autoimmune pancreatitis. Jpn J Radiol. 2011;29:194-201.
 
3) Ohshima K, Sogabe Y, Sato Y. The usefulness of infraorbital nerve enlargement on MRI imaging in clinical diagnosis of IgG4-related orbital disease. Jpn J Ophthalmol. 2012;56:380-2.
PubMed
4) Sogabe Y, Miyatani K, Goto R, et al. Pathological findings of infraorbital nerve enlargement in IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2012;56:511-4.
 
5) Inoue D, Zen Y, Sato Y, et al. IgG4-Related Perineural Disease. Int J Rheumatol. 2012;2012:401890.
PubMed
6) Sogabe Y, Ohshima K, Azumi A, et al. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol. 2014;252:531-8.
PubMed
7) Inoue D, Yoneda N, Yoshida K, et al. Imaging and pathological features of gastric lesion of immunoglobulin G4-related disease:A case report and review of the recent literature. Mod Rheumatol. 2016 Jul 21:1-5. [Epub ahead of print]
 
8) Inoue K, Okubo T, Kato T, et al. IgG4-related stomach muscle lesion with a renal pseudotumor and multiple renal rim-like lesions:A rare manifestation of IgG4-related disease. Mod Rheumatol. 2015 Sep 18:1-5. [Epub ahead of print]
 
9) Kawano H, Ishii A, Kimura T, et al. IgG4-related disease manifesting the gastric wall thickening. Pathol Int. 2016;66:23-8.
PubMed
10) Goto H, Takahira M, Azumi A;Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1-7.
 
11) Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061-7.
PubMed
P.87 掲載の参考文献
1) Yamaguchi Y, Kanetsuna Y, Honda K, et al;Japanese study group on IgG4-related nephropathy. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012;43:536-49.
 
2) Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343-52.
PubMed
3) Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016-23.
PubMed
4) Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83:455-62.
PubMed
5) Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615-26.
PubMed
6) Kawano M, Mizushima I, Yamaguchi Y, et al. Immunohistochemical Characteristics of IgG4-Related Tubulointerstitial Nephritis:Detailed Analysis of 20 Japanese Cases. Int J Rheumatol. 2012;2012:609795.
PubMed
7) Ito K, Yamada K, Mizushima I, et al. Henoch-Schonlein purpura nephritis in a patient with IgG4-related disease:a possible association. Clin Nephrol. 2013;79:246-52.
 
8) Yamada K, Zoshima T, Ito K, et al. A case developing minimal change disease during the course of IgG4-related disease. Mod Rheumatol. 2015 Mar 24:1-4. [Epub ahead of print]
 
9) 井上大, 川野充弘, 山田和徳, 他. 腎・尿路病変. In:川茂幸, 他編. IgG4関連疾患アトラス. 金沢:前田書店;2012. p. 74-80.
 
10) Kim B, Kim JH, Byun JH, et al. IgG4-related kidney disease:MRI findings with emphasis on the usefulness of diffusion-weighted imaging. Eur J Radiol. 2014;83:1057-62.
 
11) Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22:414-8.
PubMed
12) Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610-7.
 
13) Asano J, Watanabe T, Oguchi T, et al. Association Between Immunoglobulin G4-related Disease and Malignancy within 12 Years after Diagnosis:An Analysis after Longterm Followup. J Rheumatol. 2015;42:2135-42.
PubMed
14) Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis:a case-control study and review of the literature. Pancreas. 2014;43:417-21.
PubMed
15) Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53:171-6.
PubMed
16) Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease:dataset of 235 consecutive patients. Medicine(Baltimore). 2015;94:e680.
PubMed
P.100 掲載の参考文献
1) Moriyama M, Furukawa S, Kawano S, et al. The diagnostic utility of biopsies from the submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Int J Oral Maxillofac Surg. 2014;43:1276-81.
PubMed
2) Abe A, Takano K, Seki N, et al. The clinical characteristics of patients with IgG4-related disease with infiltration of the labial salivary gland by IgG4-positive cells. Mod Rheumatol. 2014;24:949-52.
PubMed
3) Akiyama M, Kaneko Y, Yamaoka K, et al. Subclinical labial salivary gland involvement in IgG4-related disease affected with vital organs. Clin Exp Rheumatol. 2015;33:949-50.
PubMed
4) Moriyama M, Ohta M, Furukawa S, et al. The diagnostic utility of labial salivary gland biopsy in IgG4-related disease.Mod Rheumatol. 2016;26:725-9.
PubMed
5) Akiyama M, Kaneko Y, Hayashi Y, et al. IgG4-related disease involving vital organs diagnosed with lip biopsy:A case report and literature review. Medicine(Baltimore). 2016;95:e3970.
PubMed
6) Doe K, Hohtatsu K, Lee S, et al. [Case report:Usefulness of lip biopsy for the diagnosis of IgG4-related diseases with retroperitoneal fibrosis:report of a case]. Nihon Naika Gakkai Zasshi. 2011;100:1645-7.
PubMed
7) Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis:CT findings in 17 patients. Radiology. 2011;261:625-33.
PubMed
8) Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis:a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33:1833-9.
PubMed
9) Kasashima S, Zen Y, Kawashima A, et al. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. Retroperitoneal fibrosis:a clinicopathologic study with respect to immunoglobulin G4. J Vasc Surg. 2009;49:1264-71.
 
10) Kasashima S, Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol. 2011;23:18-23.
PubMed
11) Mizushima I, Inoue D, Kawano M. Retroperitoneal fibrosis/periaortitis and hydronephrosis. In:Saito T, et al, editors. IgG4-related kidney disease. Berlin:Springer;2016. p. 159-71.
 
12) Mizushima I, Inoue D, Yamamoto M, et al. Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis:a retrospective multicenter study. Arthritis Res Ther. 2014;16:R156.
PubMed
P.110 掲載の参考文献
1) Hamaguchi Y, Yamada K, Kawano M, et al. Prurigo nodularis-like skin eruptions in a patient with IgG4-related disease. Eur J Dermatol. 2013;23:541-2.
 
2) Yamada K, Hamaguchi Y, Saeki T, et al. Investigations of IgG4-related disease involving the skin. Mod Rheumatol. 2013;23:986-93.
PubMed
3) Tokura Y, Yagi H, Yanaguchi H, et al. IgG4-related skin disease. Br J Dermatol. 2014;171:959-67.
PubMed
4) Tabata T, Kamisawa T, Hara S, et al. Intraductal papillary mucinous neoplasm of the pancreas and IgG4-related disease:a coincidental association. Pancreatology. 2013;13:379-83.
PubMed
5) Bateman AC, Culver EL, Sommerlad M, et al. Intraduct papillary mucinous neoplasm of the pancreas:a tumour linked with IgG4-related disease? J Clin Pathol. 2013;66:671-5.
PubMed
6) Vaquero EC, Salcedo MT, Cuatrecasas M, et al. Autoimmune pancreatitis type-1 associated with intraduct papillary mucinous neoplasm: report of two cases. Pancreatology. 2014;14:316-8.
 
P.120 掲載の参考文献
1) Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343-52.
PubMed
2) Asai S, Okami K, Nakamura N, et al. Sonographic appearance of the submandibular glands in patients with immunoglobulin G4-related disease. J Ultrasound Med. 2012;31:489-93.
PubMed
3) Asai S, Okami K, Nakamura N, et al. Localized or diffuse lesions of the sub-mandibular glands in immunoglobulin g4-related disease in association with differential organ involvement. J Ultrasound Med. 2013;32:731-6.
 
4) Takagi Y, Nakamura H, Origuchi T, et al. IgG4-related Mikulicz's disease:ultrasonography of the salivary and lacrimal glands for monitoring the efficacy of corticosteroid therapy. Clin Exp Rheumatol. 2013;31:773-5.
PubMed
5) Shimizu M, Okamura K, Kise Y, et al. Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis(Mikulicz's disease)and for differentiating it from Sjogren's syndrome(SS), with an emphasis on sonography. Arthritis Res Ther. 2015;17:223.
PubMed
6) Nishimori I, Tamakoshi A, Kawa S, et al;Research Committee on Intractable Pancreatic Diseases, the Ministry of Health and Welfare of Japan. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis:findings from a nationwide survey in Japan. Pancreas. 2006;32:244-8.
 
7) Tanaka S, Kobayashi T, Nakanishi K, et al. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet. 2000;356:910-1.
PubMed
8) Masuda A, Shiomi H, Matsuda T, et al. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis. Pancreatology. 2014;14:361-5.
PubMed
9) Ito N, Yagi K, Kawano M, et al. Analysis of pancreatic endocrine function in patients with IgG4-related diseases, in whom autoimmune pancreatitis was ruled out by diagnostic imaging. Endocr J. 2014;61:765-72.
PubMed
P.130 掲載の参考文献
1) Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease:dataset of 235 consecutive patients. Medicine(Baltimore). 2015;94:e680.
PubMed
2) Kamisawa T, Takuma K, Tabata T, et al. Serum IgG4-negative autoimmune pancreatitis. J Gastroenterol. 2011;46:108-16.
PubMed
3) 原精一, 神澤輝実, 田畑拓久, 他. 血中IgG4陰性の自己免疫性膵炎. In:川茂幸, 他編. IgG4関連疾患アトラス. 金沢:前田書店;2012. p. 34-8.
 
P.135 掲載の参考文献
1) Hart PA, Smyrk TC, Chari ST. Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation:IgG4-related disease without IgG4. Mod Pathol. 2015;28:238-47.
PubMed
2) Nakano E, Kanno A, Masamune A, et al. IgG4-unrelated type 1 autoimmune pancreatitis. World J Gastroenterol. 2015;21:9808-16.
PubMed
P.152 掲載の参考文献
1) Sato Y, Kojima M, Takata K, et al. Systemic IgG4-related lymphadenopathy:a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol. 2009;22:589-99.
PubMed
2) Sato Y, Kojima M, Takata K, et al. Multicentric Castleman's disease with abundant IgG4-positive cells:a clinical and pathological analysis of six cases. J Clin Pathol. 2010;63:1084-9.
 
3) Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343-52.
PubMed
4) Yamamoto M, Tabeya T, Naishiro Y, et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol. 2012;22:419-25.
PubMed
P.161 掲載の参考文献
1) Zoshima T, Yamada K, Hara S, et al. Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease:Two Case Reports. Am J Surg Pathol. 2016;40:495-501.
PubMed
2) Zoshima T, Kawano M, Hara S, et al. Differential diagnosis(2):Castleman disease. In:Saito T, et al, editors. IgG4-related kidney disease. Berlin:Springer;2016. p. 261-70.
 
3) Xu D, Lv J, Dong Y, et al. Renal involvement in a large cohort of Chinese patients with Castleman disease. Nephrol Dial Transplant. 2012;27 Suppl 3:iii119-25.
 
4) El Karoui K, Vuiblet V, Dion D, et al. Renal involvement in Castleman disease. Nephrol Dial Transplant. 2011;26:599-609.
PubMed
5) Sui Y, Zhao D. Report of six kidney disease-associated Castleman's disease cases. Clin Nephrol. 2015;84:344-52.
PubMed
6) Yuan XG, Hu W, Chen FF, et al. Renal complications of Castleman's disease:report of two cases and analysis of 75 cases. Clin Exp Nephrol. 2011;15:921-6.
PubMed
P.174 掲載の参考文献
1) Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implications of idiopathic multicentric castleman disease among Japanese:a report of 28 cases. Int J Surg Pathol. 2008;16:391-8.
PubMed
2) Kojima M, Nakamura S, Shimizu K, et al. Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia:a report of 16 cases. Int J Surg Pathol. 2004;12:25-30.
PubMed
3) Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease:CT findings with pathologic correlations. Radiology. 2009;251:260-70.
PubMed
4) Kurosawa S, Akiyama N, Ohwada A, et al. Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia accompanied with cutaneous involvement and renal dysfunction. Jpn J Clin Oncol. 2009;39:682-5.
PubMed
5) Kojima M, Nakamura N, Otuski Y, et al. Pulmonary lesion of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia appears to be a cause of lymphoplasmacytic proliferation of the lung:a report of five cases. Pathol Res Pract. 2008;204:185-90.
 
P.185 掲載の参考文献
1) Zoshima T, Yamada K, Hara S, et al. Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease:Two Case Reports. Am J Surg Pathol. 2016;40:495-501.
PubMed
2) 佐藤康晴, 吉野正. リンパ節からみた鑑別診断(Castleman病を中心に). In:川茂幸, 他編. IgG4関連疾患-実践的臨床から病因へ. 金沢:前田書店;2015;p. 47-50.
 
P.191 掲載の参考文献
1) Menon MP, Evbuomwan MO, Rosai J, et al. A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells:another red herring or a true association with IgG4-related disease? Histopathology. 2014;64:455-9.
PubMed
2) Liu L, Perry AM, Cao W, et al. Relationship between Rosai-Dorfman disease and IgG4-related disease:study of 32 cases. Am J Clin Pathol. 2013;140:395-402.
PubMed
P.197 掲載の参考文献
1) Avincsal MO, Otani K, Kanzawa M, et al. Sclerosing mesenteritis:A real manifestation or histological mimic of IgG4-related disease? Pathol Int. 2016;66:158-63.
PubMed

書評

最近チェックした商品履歴

Loading...